Evidence map›Paper›PMID 38102365›Full record

ReviewNature protocols2024

Profiling human brain vascular cells using single-cell transcriptomics and organoids.

Elizabeth E Crouch, Loukas N Diafos, Edward J Valenzuela, Kaylee Wedderburn-Pugh, Janeth Ochoa Birrueta, Jaela Caston, Tara Joseph, Madeline G Andrews, Aparna Bhaduri, Eric J Huang

Open access · greenAbstract readReview
In one paragraph

Review in Nature protocols, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Opportunities and Challenges of Brain-on-a-Chip Interfaces.Cyborg and bionic systems (Washington, D.C.) · 2025
    Review
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Elizabeth E CrouchDepartment of Pediatrics, University of California San Francisco, San Francisco, CA, USA. elizabeth.crouch@ucsf.edu.ORCID 0000-0002-4110-9892
Loukas N Diafos *Department of Pediatrics, University of California San Francisco, San Francisco, CA, USA.
Edward J Valenzuela *Department of Pediatrics, University of California San Francisco, San Francisco, CA, USA.ORCID 0000-0003-3234-5460
Kaylee Wedderburn-PughThe Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California San Francisco, San Francisco, CA, USA.
Janeth Ochoa BirruetaDepartment of Pediatrics, University of California San Francisco, San Francisco, CA, USA.
Jaela CastonThe Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California San Francisco, San Francisco, CA, USA.
Tara JosephDepartment of Pediatrics, University of California San Francisco, San Francisco, CA, USA.
Madeline G AndrewsThe Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California San Francisco, San Francisco, CA, USA.
Aparna BhaduriThe Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California San Francisco, San Francisco, CA, USA.ORCID 0000-0003-4625-6899
Eric J HuangThe Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California San Francisco, San Francisco, CA, USA. eric.huang2@ucsf.edu.ORCID 0000-0002-5381-3801
University of California, San Francisco · USSan Francisco VA Medical Center · USUniversity of California, Los Angeles · US

Funding

Pediatric Scientist Development Program (PSDP) [K12]K12HD000850 · NICHD · YALE UNIVERSITY · PI Sallie R. Permar · 1987 to 2026
$44.1M
Research BaseP30DK063720 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI VAISSE, CHRISTIAN · 2003 to 2019
$21.8M
Regulation of Cellular Pathwaysin Human Brain DevelopmentP01NS083513 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ALVAREZ-BUYLLA, ARTURO · 2014 to 2024
$12.6M
Mapping the Developing Human Neocortex by Massively Parallel Single Cell AnalysisU01MH105989 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KRIEGSTEIN, ARNOLD · 2014 to 2016
$5.1M
Restorative practice in repairing harm and promoting safe and inclusive practices in the laboratory.T32GM136547 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Adrian Erlebacher, Anita Sil · 2020 to 2026
$4.5M
Mural stem cells in normal development and germinal matrix hemorrhage in the preterm human brainK08NS116161 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CROUCH, ELIZABETH ERIN · 2021 to 2025
$1.1M
Understanding Brain Development Through the Lens of MetabolismR00NS111731 · NINDS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BHADURI, APARNA · 2021 to 2023
$738k
Improving Brain Organoid Models by Mediating Metabolic DysregulationR00MH125329 · NIMH · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI ANDREWS, MADELINE · 2022 to 2024
$722k
Understanding Brain Development Through the Lens of MetabolismK99NS111731 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BHADURI, APARNA · 2019 to 2020
$204k
Improving Brain Organoid Models by Mediating Metabolic DysregulationK99MH125329 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ANDREWS, MADELINE · 2020 to 2021
$164k
American Heart Association (American Heart Association, Inc.) 857876California Institute for Regenerative Medicine (CIRM) no numberCalifornia Institute for Regenerative Medicine (CIRM) SFSU EDUC2-12693NICHD NIH HHS K12 HD000850NIDDK NIH HHS P30 DK063720NIGMS NIH HHS T32 GM136547NIMH NIH HHS K99 MH125329NIMH NIH HHS R00 MH125329NIMH NIH HHS U01 MH105989NINDS NIH HHS K08 NS116161NINDS NIH HHS K99 NS111731NINDS NIH HHS P01 NS083513NINDS NIH HHS R00 NS111731U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 5K12HD000850-34U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases) DK063720U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) MH105989U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) MH125329U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) NS083513U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) NS111731U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) NS116161
6 · The paper itself

Abstract

Angiogenesis and neurogenesis are functionally interconnected during brain development. However, the study of the vasculature has trailed other brain cell types because they are delicate and of low abundance. Here we describe a protocol extension to purify prenatal human brain endothelial and mural cells with FACS and utilize them in downstream applications, including transcriptomics, culture and organoid transplantation. This approach is simple, efficient and generates high yields from small amounts of tissue. When the experiment is completed within a 24 h postmortem interval, these healthy cells produce high-quality data in single-cell transcriptomics experiments. These vascular cells can be cultured, passaged and expanded for many in vitro assays, including Matrigel vascular tube formation, microfluidic chambers and metabolic measurements. Under these culture conditions, primary vascular cells maintain expression of cell-type markers for at least 3 weeks. Finally, we describe how to use primary vascular cells for transplantation into cortical organoids, which captures key features of neurovascular interactions in prenatal human brain development. In terms of timing, tissue processing and staining requires ~3 h, followed by an additional 3 h of FACS. The transplant procedure of primary, FACS-purified vascular cells into cortical organoids requires an additional 2 h. The time required for different transcriptomic and epigenomic protocols can vary based on the specific application, and we offer strategies to mitigate batch effects and optimize data quality. In sum, this vasculo-centric approach offers an integrated platform to interrogate neurovascular interactions and human brain vascular development.

Indexed as

NeurogenesisOrganoidsBrainGene Expression ProfilingHumansTranscriptome

Identifiers

PMID38102365
PMCPMC11537086
OpenAlexW4389785011

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.